• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 20 Results
Document Number CR220432
 
 1 
 2 
 > 
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas c 303  {Albumin Gen.2} 
CR220432 k033009 Albumin General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Ammonia II} 
CR220432 k183517 Ammonia General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Bicarbonate Liquid} 
CR220432 k031879 Carbon dioxide, total (CO2) General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Bilirubin Total Gen.3} 
CR220432 K131544 Bilirubin, direct General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Calcium Gen.2} 
CR220432 K113521 Calcium, total General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Creatine Kinase} 
CR220432 k160570 Creatine kinase (CK) General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Creatinine Jaffe Gen.2} 
CR220432 k951595 Creatinine General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Creatinine plus ver.2} 
CR220432 k024098 Creatinine General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Fructosamine} 
CR220432 k951595 Fructosamine General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {ISE indirect Na-K-Cl for Gen.2} 
CR220432 k060373 Sodium General Chemistry MODERATE 12/05/2022

-
-